Contribution of the OATP1B subfamily to cancer biology and treatment.

W D Figg, T M Sissung, K M Reece, S Spencer

Journal: Clinical pharmacology and therapeutics 2012;92(5):658-60

PMID: 23010650

Abstract

The organic anion transporter 1B (OATP1B) subfamily consists of OATP1B1 and OATP1B3. These transporters have generally been considered liver-specific; however, recent evidence demonstrates that they are also expressed in extrahepatic tissues and in some tumors. This review discusses the potential influence of extrahepatic OATP1B expression on homeostasis and pathophysiology and its implications for pharmacotherapy in general.

Address: Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.